Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 7 of about 5 companies and 2 funds for MARK HAHN�
Company Exchange Symbol Last price Quote change Market cap
Cempra Inc NASDAQ CEMP 18.08 +0.25 (1.40%) 883.69M
Cempra, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing differentiated antibiotics for the acute care and community ...
Executive:
Mark W. Hahn
GlycoMimetics Inc NASDAQ GLYC 8.12 +0.04 (0.50%) 184.26M
GlycoMimetics, Inc. is a clinical-stage biotechnology company. The Company focuses on the discovery and development of glycomimetic drugs.
Executive:
Mark A Goldberg MD
Canamex Resources Corp CVE CSQ 0.0450 0.0000 (0.00%) 5.99M
Canamex Resources Corp. (Canamex) is engaged in the acquisition and exploration of mining properties. The Company's projects include Bruner Property and ...
Executive:
Mark A. Billings
PRECOR INCORPORATED Private
At the core of this company's operations is an innate desire to help customers train their core -- to help its bottom line. Precor makes a variety of ...
Executive:
Mark Gooding
Cempra Holdings, LLC Private
Cempra Holdings isn't afraid of a little staph, or pneumonia for that matter. The company is in the clinical stages of developing antibiotics that treat ...
Executive:
Mark W. Hahn
Mutual Fund Symbol Nav Nav change
Principal Dynamic High Yield Explorer Fund Institutional Class Shares PDYIX 9.09 -0.02 (-0.22%)
The investment seeks to provide a high level of current income with an emphasis on managing volatility. Under normal circumstances, the fund invests at ...
Executive:
Mark P. Denkinger.
Principal Dynamic High Yield Explorer Fund Class A Shares PDYAX 9.06 -0.01 (-0.11%)
The investment seeks to provide a high level of current income with an emphasis on managing volatility. Under normal circumstances, the fund invests at ...
Executive:
Mark P. Denkinger.